Harvard Bioscience (HBIO) Cash from Investing Activities (QoQ) (2010 - 2026)
Harvard Bioscience (HBIO) Cash from Investing Activities (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn |
| 10 | Harvard Bioscience | 26.75 Mn | 19.65 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.51% |
| Dec 31, 2025 | -72.13% |
| Sep 30, 2025 | -49.36% |
| Jun 30, 2025 | 65.89% |
| Mar 31, 2025 | -46.57% |
| Dec 31, 2024 | 58.06% |
| Sep 30, 2024 | -342.58% |
| Jun 30, 2024 | 303.56% |
| Mar 31, 2024 | 78.79% |
| Dec 31, 2023 | -164.59% |
| Sep 30, 2023 | 35.84% |
| Jun 30, 2023 | -317.01% |
| Mar 31, 2023 | 222.55% |
| Dec 31, 2022 | 46.83% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 6.16% |
| Mar 31, 2022 | -31.56% |
| Dec 31, 2021 | 25.42% |
| Sep 30, 2021 | -133.01% |
| Jun 30, 2021 | 31.56% |